ODEVIXIBAT EFFICACY AND SAFETY ACROSS PATIENT SUBGROUPS: AN EVALUATION OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS

被引:0
|
作者
Sturm, Ekkehard [1 ]
Artan, Reha [2 ]
Baumann, Ulrich [3 ]
Czubkowski, Piotr [4 ]
Gupte, Girish [5 ]
Durmaz, Ozlem [6 ]
Gonzales, Emmanuel M. [7 ]
Grammatikopoulos, Tassos [8 ,9 ]
Kamath, Binita M. [10 ]
Lachaux, Alain [11 ]
McKiernan, Patrick [5 ]
Ozen, Hasan [12 ]
D'Antiga, Lorenzo [13 ]
Van Der Woerd, Wendy [14 ]
Lacaille, Florence [15 ]
Rajwal, Sanjay [16 ]
Roquelaure, Bertrand [17 ]
Soufi, Nisreen [18 ]
Shteyer, Eyal [19 ]
Tessier, Mary Elizabeth [20 ]
Gu, Tao [21 ]
Yu, Qifeng [21 ]
Stein, Philip [21 ]
Clemson, Christine [21 ]
Mattsson, Jan P. [21 ]
Dalgic, Buket [22 ]
机构
[1] Univ Childrens Hosp Tubingen, Tubingen, Germany
[2] Akdeniz Univ, Antalya, Turkiye
[3] Hannover Med Sch, Hannover, Germany
[4] Childrens Mem Hlth Inst, Warsaw, Poland
[5] Birmingham Womens & Childrens NHS Fdn Trust, Birmingham, England
[6] Istanbul Univ, Istanbul Fac Med, Istanbul, Turkiye
[7] Univ Paris Saclay, Hepatinov, Inserm U 1193, Paris, France
[8] Kings Coll London, London, England
[9] Kings Coll Hosp NHS Trust, London, England
[10] Hosp Sick Children, Toronto, ON, Canada
[11] Hosp Civils Lyon, Lyon, France
[12] Hacettepe Univ, Fac Med, Ankara, Turkiye
[13] Azienda Osped Papa Giovanni XXIII, Bergamo, Italy
[14] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Utrecht, Netherlands
[15] Hop Univ Necker Enfants Malades, Paris, France
[16] Leeds Childrens Hosp, Leeds, England
[17] Hosp Timone, CHU, Marseille, France
[18] Childrens Hosp Los Angeles, Los Angeles, CA USA
[19] Shaare Zedek Med Ctr, Jerusalem, Israel
[20] Texas Childrens Hosp, Baylor Coll Med, Houston, TX USA
[21] Albireo Pharma Inc, Boston, MA USA
[22] Gazi Univ, Fac Med, Ankara, Turkiye
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
4616-C
引用
收藏
页码:S2104 / S2106
页数:3
相关论文
共 50 条
  • [1] Improvements in quality of life in odevixibat responders and nonresponders: an analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies
    Mack, Cara L.
    Gwaltney, Chad
    Ni, Quanhong
    Yu, Qifeng
    Valcheva, Velichka
    Kjems, Lise
    Horn, Patrick
    [J]. JOURNAL OF HEPATOLOGY, 2022, 77 : S517 - S517
  • [2] ODEVIXIBAT THERAPY IMPROVES CLINICALLY MEANINGFUL ENDPOINTS IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS: DATA FROM THE PEDFIC 1 AND PEDFIC 2 TRIALS
    Thompson, Richard J.
    D'Antiga, Lorenzo
    Gonzales, Emmanuel
    Karpen, Saul J.
    Kjems, Lise
    Loomes, Kathleen
    Mack, Cara L.
    Ni, Quanhong
    Verkade, Henkjan J.
    Horn, Patrick
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1296 - S1296
  • [3] HEPATIC PARAMETERS, GROWTH, AND SLEEP WITH RESPONDERS AND NONRESPONDERS TO ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    McKiernan, Patrick James
    Sturm, Ekkehard
    Kamath, Binita
    Thompson, Richard J.
    Gonzales, Emmanuel M.
    Lachaux, Alain
    Baumann, Ulrich
    Shteyer, Eyal
    Czubkowski, Piotr
    Artan, Reha
    Dalgic, Buket
    Ozen, Hasan
    Gupte, Girish
    Grammatikopoulos, Tassos
    Karpen, Saul J.
    Ni, Quanhong
    Kjems, Lise
    Horn, Patrick
    [J]. HEPATOLOGY, 2021, 74 : 1164A - 1164A
  • [4] ODEVIXIBAT EFFECTS ON CHOLESTASIS-RELATED PARAMETERS: ANALYSIS OF POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    Thompson, Richard J.
    Artan, Reha
    Baumann, Ulrich
    Czubkowski, Piotr
    Dalgic, Buket
    Durmaz, Ozlem
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Horn, Patrick
    Lachaux, Alain
    Mckiernan, Patrick
    Ozen, Hasan
    Rajwal, Sanjay R.
    Roquelaure, Bertrand
    Sturm, Ekkehard
    Verkade, Henkjan J.
    Yu, Qifeng
    Kjems, Lise
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S1296 - S1297
  • [5] Odevixibat effects on cholestasis-related parameters: Analysis of pooled data from the PEDFIC 1 and PEDFIC 2 studies in children with progressive familial intrahepatic cholestasis
    Thompson, Richard
    Artan, Reha
    Baumann, Ulrich
    Czubkowski, Piotr
    Dalgic, Buket
    Durmaz, Ozlem
    Gonzales, Emmanuel
    Grammatikopoulos, Tassos
    Gupte, Girish
    Horn, Patrick
    Lachaux, Alain
    McKiernan, Patrick
    Ozen, Hasan
    Rajwal, Sanjay
    Roquelaure, Bertrand
    Sturm, Ekkehard
    Verkade, Henkjan
    Yu, Qifeng
    Kjems, Lise
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S687 - S687
  • [6] Odevixibat therapy improves clinically meaningful end points in children with progressive familial intrahepatic cholestasis: Data from the PEDFIC 1 and PEDFIC 2 trials
    Thompson, Richard
    D'Antiga, Lorenzo
    Gonzales, Emmanuel
    Karpen, Saul
    Kjems, Lise
    Loomes, Kathleen
    Mack, Cara
    Ni, Quanhong
    Verkade, Henkjan
    Horn, Patrick
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S688 - S688
  • [7] EFFECTS ON SERUM BILE ACIDS, PRURITUS, AND SAFETY WITH UP TO 72 WEEKS OF ODEVIXIBAT TREATMENT: POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES IN CHILDREN WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    Loomes, Kathleen M.
    Verkade, Henkjan J.
    Thompson, Richard J.
    Kamath, Binita
    Hardikar, Winita
    Lacaille, Florence
    Mozer-Glassberg, Yael
    Shteyer, Eyal
    Calvo, Pier Luigi
    Dalgic, Buket
    Grammatikopoulos, Tassos
    Rajwal, Sanjay
    Vittorio, Jennifer M.
    Soufi, Nisreen
    McKiernan, Patrick James
    Tessier, Mary Elizabeth
    Yu, Qifeng
    Kjems, Lise
    Horn, Patrick
    [J]. HEPATOLOGY, 2021, 74 : 1159A - 1160A
  • [8] EFFECT OF ODEVIXIBAT IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS TYPE 2 WITH AT LEAST 1 SEVERE MUTATION (BSEP3 COMPOUND HETEROZYGOTES): POOLED DATA FROM THE PEDFIC 1 AND PEDFIC 2 STUDIES
    Verkade, Henkjan J.
    Thompson, Richard J.
    Sturm, Ekkehard
    Baumann, Ulrich
    Gonzales, Emmanuel M.
    D'Antiga, Lorenzo
    Valcheva, Velichka
    Ni, Quanhong
    Clemson, Christine
    [J]. HEPATOLOGY, 2022, 76 : S1548 - S1549
  • [9] Substantial clinical benefits with odevixibat treatment across progressive familial intrahepatic cholestasis genetic deficiencies: subgroup analysis of serum bile acids, pruritus, and safety using pooled data from the PEDFIC 1 and 2 studies
    Thompson, Richard
    Horn, Patrick
    Houwen, Roderick H. J.
    Lacaille, Florence
    Ni, Quanhong
    Stein, Philip
    Tessier, Mary Elizabeth
    Thompson, Carrie
    Vittorio, Jennifer
    Kjems, Lise
    [J]. JOURNAL OF HEPATOLOGY, 2021, 75 : S684 - S685
  • [10] SERUM BILE ACID LEVELS, PRURITUS SCORES, AND GROWTH OVER TIME IN ODEVIXIBAT RESPONDERS: POOLED DATA FROM THE PEDFIC STUDIES IN PATIENTS WITH PROGRESSIVE FAMILIAL INTRAHEPATIC CHOLESTASIS
    D'Antiga, Lorenzo
    Gonzales, Emmanuel M.
    Sokal, Etienne
    Hardikar, Winita
    Verkade, Henkjan J.
    Mattsson, Jan P.
    Ni, Quanhong
    Stein, Philip
    [J]. HEPATOLOGY, 2022, 76 : S1547 - S1548